Grand Rapids, Mich.; Los Angeles, Goleta, and Irvine, Calif.; Toronto, Ontario, Canada; Sea Girt, N.J.; South Nashville, Tenn.; Houston, Texas; Washington, D.C., and Eugene, Ore. From the Bengtson Center for Aesthetics and Plastic Surgery; the Division of Plastic Surgery, Keck School of Medicine, University of Southern California; private practice; the Center for Breast and Body Contouring; Allergan Medical; Maxwell Aesthetics; Allergan, Inc.; Baylor College of Medicine; Georgetown University Hospital; and Jewell Plastic Surgery Center.
Plast Reconstr Surg. 2011 Jul;128(1):1-7. doi: 10.1097/PRS.0b013e318217fdb0.
The goal of this consensus is to establish an algorithm for the management of patients who develop a late or delayed periprosthetic fluid collection. A work group of practicing plastic surgeons and device industry physicians met periodically by teleconference and discussed issues pertinent to the diagnosis and management of late periprosthetic fluid collections in patients with breast implants. Based on these meetings, treatment recommendations and a treatment algorithm were prepared in association with an editorial assistant.
The work group participants discussed optimal care approaches developed in their private practices and from evidence in the literature.
The consensus algorithm and treatment and management recommendations represent the consensus of the group.
The group concluded that late periprosthetic fluid collection (arbitrarily defined as occurring ≥ 1 year after implant) is an infrequently reported occurrence (0.1 percent) after breast implant surgery and that, at a minimum, management should include clinically indicated ultrasound-guided aspiration of fluid, with appropriate cultures and cytologic testing. Further evaluation and additional treatment is recommended for recurrence of periprosthetic fluid collection after aspiration, or clinical suspicion of infection or neoplasia.
本共识的目的是建立一种算法,用于管理出现晚期或延迟性假体周围积液的患者。一个由执业整形外科医生和器械行业医生组成的工作组通过电话会议定期开会,讨论与假体周围晚期积液的诊断和管理相关的问题,这些患者都接受了乳房植入物手术。基于这些会议,与编辑助理一起准备了治疗建议和治疗算法。
工作组参与者讨论了在私人诊所和文献中发展起来的最佳护理方法。
共识算法以及治疗和管理建议代表了小组的共识。
该小组得出结论,假体周围晚期积液(任意定义为植入后≥1 年发生)是乳房植入手术后罕见报告的事件(0.1%),至少应包括临床指征的超声引导下积液抽吸,并进行适当的培养和细胞学检查。对于抽吸后假体周围积液复发或临床怀疑感染或肿瘤,建议进一步评估和额外治疗。